258 related articles for article (PubMed ID: 1597914)
1. Intravenous immunoglobulin therapy for toxic shock syndrome.
Barry W; Hudgins L; Donta ST; Pesanti EL
JAMA; 1992 Jun; 267(24):3315-6. PubMed ID: 1597914
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
Perez CM; Kubak BM; Cryer HG; Salehmugodam S; Vespa P; Farmer D
Am J Med; 1997 Jan; 102(1):111-3. PubMed ID: 9209207
[No Abstract] [Full Text] [Related]
3. Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review.
Cawley MJ; Briggs M; Haith LR; Reilly KJ; Guilday RE; Braxton GR; Patton ML
Pharmacotherapy; 1999 Sep; 19(9):1094-8. PubMed ID: 10610017
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
[TBL] [Abstract][Full Text] [Related]
5. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
[TBL] [Abstract][Full Text] [Related]
6. [Streptococcal toxic shock syndrome or Kawasaki disease? Two case studies of children with group A streptococcal pneumonia empyema].
Bosland A; Arlaud K; Rousset-Rouvière C; Fouilloux V; Paut O; Dubus JC; Bosdure E
Arch Pediatr; 2011 Dec; 18(12):1310-4. PubMed ID: 22041597
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.
Lamothe F; D'Amico P; Ghosn P; Tremblay C; Braidy J; Patenaude JV
Clin Infect Dis; 1995 Dec; 21(6):1469-70. PubMed ID: 8749635
[TBL] [Abstract][Full Text] [Related]
8. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
Sriskandan S; Ferguson M; Elliot V; Faulkner L; Cohen J
J Antimicrob Chemother; 2006 Jul; 58(1):117-24. PubMed ID: 16670109
[TBL] [Abstract][Full Text] [Related]
9. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Abinun M; Cant AJ
Lancet; 1994 Jan; 343(8892):300. PubMed ID: 7905129
[No Abstract] [Full Text] [Related]
10. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.
Stevens DL
Clin Infect Dis; 1998 Mar; 26(3):639-41. PubMed ID: 9524836
[No Abstract] [Full Text] [Related]
11. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature.
Tilanus AM; de Geus HR; Rijnders BJ; Dwarkasing RS; van der Hoven B; Bakker J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e208-12. PubMed ID: 19914115
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Therapeutic Strategy With Delayed Debridement for Culture-Negative Invasive Group A Streptococcal Infections Diagnosed by Metagenomic Next-Generation Sequencing.
He W; Wu C; Zhong Y; Li J; Wang G; Yu B; Xu P; Xiao Y; Tang T
Front Public Health; 2022; 10():899077. PubMed ID: 35646803
[TBL] [Abstract][Full Text] [Related]
13. Dilemmas in the treatment of invasive Streptococcus pyogenes infections.
Stevens DL
Clin Infect Dis; 2003 Aug; 37(3):341-3. PubMed ID: 12884157
[No Abstract] [Full Text] [Related]
14. Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics.
Chiu CH; Ou JT; Chang KS; Lin TY
Infection; 1997; 25(1):47-8. PubMed ID: 9039540
[No Abstract] [Full Text] [Related]
15. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
Baxter M; Morgan M
Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491
[TBL] [Abstract][Full Text] [Related]
16. Case 28-2002: a traveler with a rapidly progressive soft-tissue infection.
Johnson JR; Gandhi R
N Engl J Med; 2003 Jan; 348(2):176-7; author reply 176-7. PubMed ID: 12519934
[No Abstract] [Full Text] [Related]
17. [Necrotizing fasciitis of the eyelids and toxic shock syndrome due to Streptococcus pyogenes].
Bustos B R; Soto G G; Hickmann O L; Torres B C
Rev Chilena Infectol; 2009 Apr; 26(2):152-5. PubMed ID: 19621147
[TBL] [Abstract][Full Text] [Related]
18. Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome.
Feigenberg T; Sela HY; Applbaum YH; Mankuta D
Isr Med Assoc J; 2008 Jun; 10(6):483-4. PubMed ID: 18669156
[No Abstract] [Full Text] [Related]
19. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.
Schrage B; Duan G; Yang LP; Fraser JD; Proft T
Clin Infect Dis; 2006 Sep; 43(6):743-6. PubMed ID: 16912949
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of polyspecific intravenous immunoglobulin therapy in streptococcal toxic shock syndrome.
Arends JE; Harkisoen S
Clin Infect Dis; 2015 Jan; 60(2):324. PubMed ID: 25313253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
